|
Q1 2018
Filed on May 03, 2018
|
1,000
|
$6.34 - $6.98
$6.34K - $6.98K
|
|
|
Q1 2018
Filed on May 03, 2018
|
1,300
|
$9.02 - $12.65
$11.7K - $16.4K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
100
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
101
|
$65.15 - $72.49
$6.58K - $7.32K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
34,566
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
1,096
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
236
|
$53.89 - $72.36
$12.7K - $17.1K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
18,572
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
92,620
|
N/A
|
|
Level 3 Communications Inc
|
Q4 2017
Filed on Feb 05, 2018
|
6
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
2,200
|
N/A
|
|
National Westminster Bk PLC
|
Q4 2017
Filed on Feb 05, 2018
|
1,430
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
800
|
$54.71 - $59.16
$43.8K - $47.3K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
1,275
|
$13.55 - $14.5
$17.3K - $18.5K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
35
|
$24.77 - $29.49
$867 - $1.03K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
100
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
300
|
$21.2 - $22.58
$6.36K - $6.77K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
50
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
613,035
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
563
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
102
|
$18.31 - $22.24
$1.87K - $2.27K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
445
|
$6.86 - $7.27
$3.05K - $3.24K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
1,400
|
$69.03 - $83.4
$96.6K - $117K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
1,572
|
$14.59 - $15.51
$22.9K - $24.4K
|
|
Oppenheimer Rev Weightd ETF
|
Q4 2017
Filed on Feb 05, 2018
|
225
|
N/A
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
1,500
|
$24.29 - $26.37
$36.4K - $39.6K
|
|
|
Q4 2017
Filed on Feb 05, 2018
|
300
|
N/A
|
|
Allied Wrld Assur Com Hldg A
|
Q3 2017
Filed on Nov 02, 2017
|
104
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
2
|
N/A
|
|
Cellular Biomedicine Group I
|
Q3 2017
Filed on Nov 02, 2017
|
1
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
34
|
$51.06 - $63.37
$1.74K - $2.15K
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
300
|
$16.85 - $17.75
$5.06K - $5.33K
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
1,455
|
N/A
|
|
Du Pont E I De Nemours & CO
|
Q3 2017
Filed on Nov 02, 2017
|
4,419
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
2,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
25
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
3,721
|
$27.36 - $30.01
$102K - $112K
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
8
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
20
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
8
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
16
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
1
|
$219.65 - $252.15
$220 - $252
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
309
|
$22.63 - $27.43
$6.99K - $8.48K
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
10,000
|
$2.14 - $4.26
$21.4K - $42.6K
|
|
Royal Bk Scotland Group PLC
|
Q3 2017
Filed on Nov 02, 2017
|
526
|
N/A
|
|
Royal Bk Scotland Group PLC
|
Q3 2017
Filed on Nov 02, 2017
|
874
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
561
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
108
|
N/A
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
25
|
$37.35 - $45.81
$934 - $1.15K
|
|
|
Q3 2017
Filed on Nov 02, 2017
|
579
|
$15.44 - $15.78
$8.94K - $9.14K
|
|